Testicular cancer is the most common cancer in men aged 15 to 40 years in the United States, Canada, and many European countries. Given the excellent prognosis of most men with testicular cancer, updates in care after treatment have become very important. This article provides a review of the available evidence, integrated with expert medical judgment, in the area of testicular cancer follow-up.
|Original language||English (US)|
|Number of pages||12|
|Journal||JNCCN Journal of the National Comprehensive Cancer Network|
|State||Published - Jun 1 2015|